CA2248317C - Anticonvulsant enantiomeric amino acid derivatives - Google Patents

Anticonvulsant enantiomeric amino acid derivatives Download PDF

Info

Publication number
CA2248317C
CA2248317C CA002248317A CA2248317A CA2248317C CA 2248317 C CA2248317 C CA 2248317C CA 002248317 A CA002248317 A CA 002248317A CA 2248317 A CA2248317 A CA 2248317A CA 2248317 C CA2248317 C CA 2248317C
Authority
CA
Canada
Prior art keywords
compound
mmol
compounds
liver
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002248317A
Other languages
English (en)
French (fr)
Other versions
CA2248317A1 (en
Inventor
Harold Kohn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp Technologies Inc
Original Assignee
Research Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21760388&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2248317(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Research Corp Technologies Inc filed Critical Research Corp Technologies Inc
Publication of CA2248317A1 publication Critical patent/CA2248317A1/en
Application granted granted Critical
Publication of CA2248317C publication Critical patent/CA2248317C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002248317A 1996-03-15 1997-03-17 Anticonvulsant enantiomeric amino acid derivatives Expired - Lifetime CA2248317C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1352296P 1996-03-15 1996-03-15
US60/013,522 1996-03-15
PCT/US1997/004579 WO1997033861A1 (en) 1996-03-15 1997-03-17 Anticonvulsant enantiomeric amino acid derivatives

Publications (2)

Publication Number Publication Date
CA2248317A1 CA2248317A1 (en) 1997-09-18
CA2248317C true CA2248317C (en) 2003-12-02

Family

ID=21760388

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002248317A Expired - Lifetime CA2248317C (en) 1996-03-15 1997-03-17 Anticonvulsant enantiomeric amino acid derivatives

Country Status (12)

Country Link
EP (2) EP1038522B1 (enExample)
JP (1) JP3145414B2 (enExample)
AT (2) ATE202079T1 (enExample)
AU (1) AU718577B2 (enExample)
CA (1) CA2248317C (enExample)
DE (3) DE69729392T2 (enExample)
DK (2) DK1038522T3 (enExample)
ES (2) ES2218024T3 (enExample)
FR (1) FR09C0006I2 (enExample)
NL (1) NL300376I1 (enExample)
PT (2) PT1038522E (enExample)
WO (1) WO1997033861A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048899A (en) * 1997-03-17 2000-04-11 Research Corporation Tech., Inc. Anticonvulsant enantiomeric amino acid derivatives
EP1642889A1 (en) 2004-10-02 2006-04-05 Schwarz Pharma Ag Improved synthesis scheme for lacosamide
EP1873527A1 (en) 2006-06-30 2008-01-02 Schwarz Pharma Ag Method for identifying CRMP modulators
US8093426B2 (en) * 2007-12-04 2012-01-10 Ranbaxy Laboratories Limited Intermediate compounds and their use in preparation of lacosamide
DE102008059155A1 (de) 2008-11-27 2010-06-02 Ratiopharm Gmbh Trockenverarbeitung und neue Formen von Lacosamid
US8440861B2 (en) 2009-08-06 2013-05-14 Medichem, S.A. Solid forms of an N-(phenylmethyl)propanamide derivative and processes of preparation
JP5564570B2 (ja) * 2009-09-25 2014-07-30 カディラ・ヘルスケア・リミテッド ラコサミドおよびその中間体の調製方法
IT1398044B1 (it) * 2010-01-29 2013-02-07 Archimica Srl Processo per la preparazione della lacosamide
WO2011095995A1 (en) 2010-02-08 2011-08-11 Natco Pharma Limited A process for the preparation of lacosamide
US8907132B2 (en) 2010-02-09 2014-12-09 Msn Laboratories Private Limited Process for preparing (R)-2-acetamido-N-benzyl-3-methoxy-propionamide
EP2399901A1 (en) 2010-06-23 2011-12-28 Archimica GmbH Intermediate for producing lacosamide and a process for its preparation and conversion to lacosamide
WO2012041986A1 (en) 2010-10-01 2012-04-05 Ucb Pharma Gmbh Process for the preparation of amino acid derivatives
EP2627639B1 (en) 2010-10-15 2021-12-22 Nektar Therapeutics N-optionally substituted aryl-2-oligomer-3-alkoxypropionamides
ES2619403T3 (es) 2010-10-19 2017-06-26 Euticals Gmbh Proceso para producir lacosamida
EP2468261A1 (en) 2010-12-02 2012-06-27 UCB Pharma GmbH Formulation of lacosamide
EP2646001A2 (en) 2010-12-02 2013-10-09 UCB Pharma GmbH Formulation of lacosamide
CN104771356A (zh) * 2014-01-09 2015-07-15 山东方明药业集团股份有限公司 一种拉科酰胺注射液及其制备方法
US11278634B1 (en) 2021-02-12 2022-03-22 Extrovis Ag Stable parenteral composition of lacosamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340902C (en) * 1985-02-15 2000-02-22 Harold L. Kohn Amino acid derivative anticonvulsant
US5378729A (en) * 1985-02-15 1995-01-03 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant

Also Published As

Publication number Publication date
AU2539497A (en) 1997-10-01
ATE268169T1 (de) 2004-06-15
DE122009000010I2 (de) 2010-10-21
EP1038522A3 (en) 2003-01-15
NL300376I1 (nl) 2009-05-06
EP0888289A1 (en) 1999-01-07
JP2000505476A (ja) 2000-05-09
DE122009000010I1 (de) 2009-05-20
FR09C0006I2 (fr) 2009-12-18
ES2157567T3 (es) 2001-08-16
CA2248317A1 (en) 1997-09-18
DE69729392D1 (de) 2004-07-08
PT1038522E (pt) 2004-10-29
WO1997033861A1 (en) 1997-09-18
FR09C0006I1 (enExample) 2009-04-17
EP0888289B1 (en) 2001-06-13
EP1038522B1 (en) 2004-06-02
DK0888289T3 (da) 2001-09-03
JP3145414B2 (ja) 2001-03-12
EP1038522A2 (en) 2000-09-27
AU718577B2 (en) 2000-04-13
ATE202079T1 (de) 2001-06-15
ES2218024T3 (es) 2004-11-16
DK1038522T3 (da) 2004-10-11
DE69705210D1 (de) 2001-07-19
DE69705210T2 (de) 2001-09-20
DE69729392T2 (de) 2005-06-02
PT888289E (pt) 2001-09-28

Similar Documents

Publication Publication Date Title
US5773475A (en) Anticonvulsant enantiomeric amino acid derivatives
EP0888289B1 (en) Anticonvulsant enantiomeric amino acid derivatives
US5914349A (en) Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
JPH09510188A (ja) １−アミノインダン及びこれらの組成物
WO1996021640A1 (en) Optically active aminoindane derivatives and preparation thereof
EP0007206B1 (en) Phenethanolamines, their formulations, preparation and use
WO2000000463A1 (en) Anticonvulsant enantiomeric amino acid derivatives
CA2893216C (fr) Derives d'aminocyclobutane, leur procede de preparation et leur utilisation a titre de medicaments
JPH08501805A (ja) キヌレニナーゼおよび／またはキヌレニン−３−ヒドロキシラーゼ阻害活性を有する２−アミノ−４−フェニル−４−オキソ酪酸誘導体
EP1590321A2 (fr) DERIVES D’ ARYLALKYLCARBAMATES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2883000A1 (fr) Derives de trifluoromethylbenzamide et leurs utilisations en therapeutique
JP3542600B2 (ja) 置換（アリールアルキルアミノベンジル）アミノプロピオンアミド誘導体及びその製造方法
EP1753725A1 (fr) Derives de tetrahydroisoquinolilsulfonamides, leur preparation et leur utilisation en therapeutique
EP1150970B1 (fr) Derives de (1-phenacy-3-phenyl-3-piperidylethyl)piperidine, procede pour leur obtention et compositions pharmaceutiques les contenant
JP2661841B2 (ja) インドリン誘導体
US4803293A (en) Tertiary amines
US6797730B2 (en) Peptide deformylase inhibitors
JPH0550499B2 (enExample)
JPH09176157A (ja) 光学活性アミノクマラン誘導体
EP0171760A2 (en) Substituted phenoxypropylaminoethoxyphenoxyacetamides
JP2005507364A (ja) ペプチドデホルミラーゼ阻害剤
JPH027306B2 (enExample)
JPH068267B2 (ja) Ｎ，ｎ−二置換フエニルセリン誘導体及びそれを有効成分とする中枢神経系用剤
JPWO2001083429A1 (ja) アニリン誘導体

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170317